NEW YORK, NY — As the world dons pink ribbons for Breast Cancer Awareness Month this October, a global movement is working to ensure that the estimated 168,000 Americans living with metastatic breast cancer (MBC) are not left in the shadows of early-detection narratives. On October 13, 2026, the #LightUpMBC campaign, organized by METAvivor Research and Support, will see more than 325 landmarks across 50 U.S. states and 20 countries illuminate in teal, green, and pink. This synchronized display of light serves as a somber reminder of the lives lost to Stage 4 breast cancer and a clarion call for the research funding necessary to turn a terminal diagnosis into a manageable, chronic condition.
Main Facts: The Reality of Stage 4 and the Scope of the Campaign
Metastatic breast cancer, also known as Stage 4, occurs when cancer cells break away from the primary site in the breast and travel through the lymphatic system or bloodstream to distant parts of the body. Most commonly, MBC affects the bones, liver, lungs, or brain. Unlike early-stage breast cancer, which can often be treated with the goal of "finishing" therapy, MBC has no known cure. Patients remain in treatment for the rest of their lives, rotating through various therapies as the cancer inevitably develops resistance to each one.
The #LightUpMBC campaign is designed to bring visibility to this specific medical reality. While traditional breast cancer awareness focuses heavily on mammograms and "survivorship," those living with MBC face a different set of challenges. The illumination of landmarks in the MBC colors—teal for hope and healing, green for the renewal of life, and pink for the origin of the disease—seeks to bridge the gap between public perception and the clinical reality of the disease.
The 2026 campaign is set to be the largest in history. Participating landmarks include architectural icons such as One World Trade Center in New York City, the Willis Tower in Chicago, and Philadelphia City Hall. Internationally, the movement has spread to Niagara Falls on the Canada-U.S. border, the Ness Bridge in Scotland, and the Mactan-Cebu International Airport in the Philippines.
Central to the day’s activities is "#LightUpMBC Live," a free virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT on October 13. Hosted by creator Tami Eagle Bowling and Broadway star Kara Lindsay, the program will feature a mix of scientific insights, patient testimonials, and high-profile musical performances. One hundred percent of the net proceeds from the campaign go directly toward funding Stage 4 research grants, a rarity in a philanthropic landscape where MBC research often receives only a small fraction of overall breast cancer funding.
Chronology: From a Single Bridge to a Global Phenomenon
The #LightUpMBC movement was born from the personal tragedy and vision of Jessica Moore, a young woman diagnosed with MBC who died in 2017 at the age of 36. Her goal was modest: she wanted to see one local landmark lit up in the colors of metastatic breast cancer to raise awareness for those, like her, whose cancer had spread.
Following her passing, her best friend Laura Inahara took up the mantle. In 2017, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to glow in teal, green, and pink. This single act of remembrance sparked a grassroots fire. What began as a local tribute quickly transformed into a national campaign, and eventually, a global initiative.
By 2020, despite the challenges of the global pandemic, the campaign transitioned into a digital-heavy format, introducing the "Live" broadcast to connect a geographically dispersed and often immunocompromised community. Over the last nine years, the campaign has raised over $2.7 million for METAvivor. This funding is critical because, historically, while Stage 4 patients account for nearly all breast cancer deaths, less than 7% of total breast cancer research funding is dedicated to investigating metastatic disease.
The 2026 iteration marks a decade-long evolution toward institutionalizing October 13 as National Metastatic Breast Cancer Awareness Day. The growth from one bridge in New Hampshire to 325 landmarks in 195 cities worldwide reflects a shifting tide in how the public and the medical community view Stage 4 advocacy.
Supporting Data: The Statistics of a Terminal Disease
The urgency behind #LightUpMBC is underscored by sobering clinical data. According to the National Cancer Institute’s SEER (Surveillance, Epidemiology, and End Results) database, approximately 42,670 people in the United States are expected to die from breast cancer in 2026. This equates to roughly 117 deaths every single day.
A common misconception is that early detection guarantees a cure. However, data shows that nearly 30% of people diagnosed with early-stage breast cancer will eventually progress to metastatic disease, sometimes years or even decades after their initial successful treatment. Furthermore, about 6% of new breast cancer cases are "de novo" metastatic, meaning the cancer has already spread to distant organs by the time it is first discovered.
The economic and social toll is equally staggering. Patients with MBC face lifelong medical expenses, with many forced to leave the workforce due to the side effects of chemotherapy, targeted therapies, and radiation. The psychological impact, often referred to as "scanxiety," involves the perpetual fear that the next imaging scan will show disease progression.
METAvivor remains the only U.S. organization that dedicated 100% of its net donations to Stage 4 research. By focusing exclusively on the metastatic stage, the organization addresses a massive gap in the research pipeline. Their peer-review process involves both scientific experts and patient advocates, ensuring that the research funded has the highest potential for immediate patient impact.
Official Responses: Leadership on the Front Lines
The leadership of METAvivor and #LightUpMBC consists largely of individuals who are themselves living with the disease, lending a unique urgency to their mission.
Dr. Kelly Shanahan, the Board President of METAvivor and a former OB-GYN, has been living with MBC since 2013. Her perspective highlights the life-extending power of research. "When I was diagnosed… I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan said. "My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
Laura Inahara, the founder of #LightUpMBC, views the campaign as a fulfillment of Jessica Moore’s legacy. "Jessica hoped to illuminate one local landmark," Inahara remarked. "Today, her legacy helps families around the world shine a light for the people they love… and has now raised over $2.7 million for critical MBC research."
Tami Eagle Bowling, the campaign director and host of the live stream, has lived with MBC for 11 years. For her, the campaign is about changing the narrative of what it means to live with Stage 4. By bringing together Tony Award-winning performers like Victoria Clark and Dorian Harewood for the broadcast, she aims to elevate the MBC conversation to a global stage, moving it beyond the confines of clinical settings and into the cultural mainstream.
Implications: Shifting the Paradigm of Breast Cancer Advocacy
The #LightUpMBC campaign represents a significant shift in the landscape of cancer advocacy. For decades, the "pink ribbon" movement has been criticized by Stage 4 patients for "pinkwashing"—a term used to describe the commercialization of breast cancer awareness that often ignores the terminal reality of the disease.
By reclaiming a day within Breast Cancer Awareness Month, METAvivor and the #LightUpMBC campaign are forcing a more nuanced conversation. The implications of this shift are threefold:
- Scientific Advancements: By funneling millions into Stage 4-specific research, METAvivor is helping to identify the mechanisms of metastasis. This research is vital for developing "maintenance" therapies that can keep cancer stable for years, effectively turning MBC into a survivable, albeit chronic, condition similar to HIV/AIDS.
- Patient Empowerment: The #LightUpMBC Live event provides a platform for patients to see others thriving with the disease for a decade or more. This visibility combats the isolation often felt by Stage 4 patients who do not fit into the "survivor" narrative celebrated by other organizations.
- Policy and Funding Shifts: As more landmarks light up and more cities officially recognize October 13, there is increased pressure on federal funding bodies, such as the National Institutes of Health (NIH), to reevaluate how research dollars are allocated. The goal is to move the needle from the current 7% allocation for MBC to a figure that more accurately reflects the percentage of deaths caused by the disease.
As the lights turn teal, green, and pink on October 13, the message is clear: awareness is no longer enough. The global community of MBC patients and their families are demanding action, research, and a future where Stage 4 is no longer a death sentence.
The public is encouraged to participate by photographing illuminated landmarks and sharing them on social media using the hashtags #LightUpMBC and #METAvivor. For those unable to visit a landmark in person, the #LightUpMBC Live broadcast offers a way to join the movement and contribute to the research that represents the only hope for a cure.
About the Author
